| | 07/May/21
| | Calyxt gene-edited soybean flops in the US Gene editing has been hyped as a way to bring products with attractive traits to market much more speedily. But so far very few products have emerged from the gene editing pipe line and those that have don’t seem to tally with the industry narrative. Calyxt's gene-edited soybean, for instance, has suffered poor farmer take-up, according to an article in the US-based investment magazine Seeking Alpha, reporting in December 2020. The article says, "the company disappointed investors with delayed product launches and slow growth", contradicting its business model that claims "a speedy development cycle using novel gene-editing technologies". GMWatch Gene editing regulation reviews spark Unite union concern Trade union Unite is urging caution over moves by both the UK and the EU to weaken regulation around the commercial use of gene editing in agriculture. Bev Clarkson, Unite national officer for food, drink and agriculture, said there were "legitimate worries" surrounding gene editing. She called on the UK and the EU to adhere to the precautionary principle in relation to its introduction. She added that gene-edited crops were being promoted on the basis of the same promises that were made for first generation GM crops – but the promises proved false. Food Manufacture DONATE TO GMWATCH __________________________________________________________ Website: http://www.gmwatch.org
Profiles: http://www.powerbase.info/index.php/GM_Watch:_Portal
Twitter: http://twitter.com/GMWatch
Facebook: http://www.facebook.com/pages/GMWatch/276951472985?ref=nf |
|
